Simultaneous Detection of Nuclear and Cytoplasmic RNA Variants Utilizing Stellaris® RNA Fluorescence In Situ Hybridization in Adherent Cells

2014 ◽  
pp. 189-199 ◽  
Author(s):  
Sally R. Coassin ◽  
Arturo V. Orjalo ◽  
Sheila J. Semaan ◽  
Hans E. Johansson
Keyword(s):  
In Situ Hybridization ◽  
Fluorescence In Situ Hybridization ◽  
Simultaneous Detection ◽  
Adherent Cells ◽  
Cytoplasmic Rna

scholarly journals Combined immunocytochemistry and fluorescence in situ hybridization for simultaneous tricolor detection of cell cycle, genomic, and phenotypic parameters of tumor cells.

1994 ◽  
Vol 42 (7) ◽  
pp. 961-966 ◽  
Author(s):  
E J Speel ◽  
J Herbergs ◽  
F C Ramaekers ◽  
A H Hopman
Keyword(s):  
In Situ Hybridization ◽  
Fluorescence In Situ Hybridization ◽  
Tumor Cells ◽  
Simultaneous Detection ◽  
Dna Probes ◽  
Accurate Localization ◽  
Fast Red ◽  
Pre Treatment ◽  
High Fluorescence

We describe the development and application of a sensitive high-resolution fluorescence alkaline phosphatase (APase)-Fast Red immunocytochemical (ICC) staining method in combination with fluorescence in situ hybridization (ISH) and bromodeoxyuridine (BrdU) detection. The high fluorescence intensity, accurate localization, and advantageous slow-fading properties make the APase-Fast Red reaction a valuable tool for detection of antigens or specific DNA probes in biological cell preparations. Since the enzyme precipitate proved to be resistant to enzymatic pre-treatment steps and stable during the entire ISH procedure, APase-Fast Red immunostaining could be combined with subsequent visualization of DNA target sequences by fluorescence ISH. The lung cancer cell lines NCI-H82 and EPLC 65 were used as a model system for simultaneous detection of cell proteins, such as the neural cell adhesion molecule (N-CAM), cytokeratin filaments, lamin or the Ki67 antigen (Ki67-Ag), and centromere-specific DNA probes for human chromosomes 1, 7, or 17. In addition, the combined ICC/ISH procedure could be extended with the immunodetection of BrdU incorporated by tumor cells in S-phase. As a consequence, a combined ICC/ISH/BrdU detection procedure is now available that enables analysis of relatively complex tumor populations on the basis of different ICC and genetic markers as well as proliferative activity.

scholarly journals Fluorescence in Situ Hybridization (FISH) for Detecting Anaplastic Lymphoma Kinase (ALK) Rearrangement in Lung Cancer: Clinically Relevant Technical Aspects

2019 ◽  
Vol 20 (16) ◽  
pp. 3939 ◽  
Author(s):  
Zhenya Tang ◽  
Lu Wang ◽  
Guilin Tang ◽  
L. Jeffrey Medeiros
Keyword(s):  
Lung Cancer ◽  
In Situ Hybridization ◽  
Fluorescence In Situ Hybridization ◽  
Simultaneous Detection ◽  
The United States ◽  
Driver Mutations ◽  
Alk Rearrangement ◽  
Technical Aspects ◽  
Anaplastic Lymphoma

In 2011, the Vysis Break Apart ALK fluorescence in situ hybridization (FISH) assay was approved by the United States Food and Drug Administration as a companion diagnostic for detecting ALK rearrangement in lung cancer patients who may benefit from treatment of tyrosine kinase inhibitor therapy. This assay is the current “gold standard”. According to updated ALK testing guidelines from the College of American Pathologists, the International Association for the Study of Lung Cancer and the Association for Molecular Pathology published in 2018, ALK immunohistochemistry is formally an alternative to ALK FISH, and simultaneous detection of multiple hot spots, including, at least, ALK, ROS1, RET, MET, ERBB2, BRAF and KRAS genes is also recommended while performing next generation sequencing (NGS)-based testing. Therefore, ALK status in a specimen can be tested by different methods and platforms, even in the same institution or laboratory. In this review, we discuss several clinically relevant technical aspects of ALK FISH, including pros and cons of the unique two-step (50- to 100-cell) analysis approach employed in the Vysis Break Apart ALK FISH assay, including: the preset cutoff value of ≥15% for a positive result; technical aspects and biology of discordant results obtained by different methods; and incidental findings, such as ALK copy number gain or amplification and co-existent driver mutations. These issues have practical implications for ALK testing in the clinical laboratory following the updated guidelines.

Simultaneous detection of X- and Y-bearing bull spermatozoa by double colour fluorescence in situ hybridization

1999 ◽  
Vol 53 (4) ◽  
pp. 407-412 ◽  
Author(s):  
Mohamed Hassanane ◽  
Andras Kovacs ◽  
Pascal Laurent ◽  
Kerstin Lindblad ◽  
Ingemar Gustavsson
Keyword(s):  
In Situ Hybridization ◽  
Fluorescence In Situ Hybridization ◽  
Simultaneous Detection

Simultaneous detection ofMYC,BVR1, andPVT1 translocations in lymphoid malignancies by fluorescence in situ hybridization

1998 ◽  
Vol 23 (3) ◽  
pp. 220-226 ◽  
Author(s):  
Katrina Rack ◽  
Eric Delabesse ◽  
Isabelle Radford-Weiss ◽  
Priscille Bourquelot ◽  
Gaëlle Le Guyader ◽  
...  
Keyword(s):  
In Situ Hybridization ◽  
Fluorescence In Situ Hybridization ◽  
Simultaneous Detection ◽  
Lymphoid Malignancies
Sign in / Sign up

Export Citation Format

Share Document